Paravasation with Cyclophosphamide – Case Report of Tissue Necrosis in a Patient with Primary Breast Cancer
- 1 September 2007
- journal article
- case report
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 30 (8-9), 452-454
- https://doi.org/10.1159/000105319
Abstract
Paravasation is a rare but severe complication of treatment with cytotoxic agents. Some anticancer drugs are considered to be of high toxicity (vesicant), some are merely irritant, and some are regarded as nearly non-toxic to healthy tissue as is the case with cyclophosphamide. Case Report: In this report, we present the first case of severe tissue damage caused by a paravasation of cyclophosphamide in a breast cancer patient receiving chemotherapy. Conclusion: Therefore, every attending oncological physician should be aware of the possibility of severe tissue damage as a consequence of cyclophosphamide paravasation.Keywords
This publication has 7 references indexed in Scilit:
- Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical ExperienceOncology Research and Treatment, 2006
- Management of Skin-Sparing Mastectomy: Results of a Survey of German HospitalsOncology Research and Treatment, 2006
- Extravasation of Chemotherapeutic Agents: Prevention and TreatmentSeminars in Oncology, 2006
- Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospitalJournal of Clinical Nursing, 2005
- Paravasation von Zytostatika: Prävention und TherapieDeutsche Medizinische Wochenschrift (1946), 2005
- Frequency of Radiation Recall Dermatitis in Adult Cancer PatientsOncology Research and Treatment, 2004
- Conservative Approach to the Treatment of Chemotherapy-Induced ExtravasationThe Journal of Dermatologic Surgery and Oncology, 1990